Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009973/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
RATIONALE: Zoledronate, clodronate, or ibandronate may delay or prevent bone metastases in
patients with nonmetastatic breast cancer. It is not yet known whether zoledronate is more
effective than clodronate or ibandronate in treating breast cancer.
PURPOSE: This randomized phase III trial is studying zoledronate to see how well it works
compared to clodronate or ibandronate in treating women who have undergone surgery for stage
I, stage II, or stage III breast cancer.
提供机构：
Vivli
创建时间：
2024-04-11
